Studies in animal models and humans that investigated intestinal immune cells, barrier function and/or inflammation in intestinal tissues together with effects on systemic glucose and/or insulin metabolism and/or weight gain during obesity and T2D were selected. The gene discussed is INS; the disease is type 2 diabetes mellitus.